HIGHLIGHTS
- who: Arshi Khanam from the Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA have published the Article: Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways, in the Journal: (JOURNAL)
- what: The authors evaluated the role of chemokine receptor 4 (CCR4) in deriving immunosuppression during CHB. While this research is focusing on the inhibitory receptors and TLRs as treatment options for CHB patients, the role of the chemokine receptors (CCRs) has been overlooked. The authors investigated the role . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.